ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).
| Authors | F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F André, C H Barrios, J Bergh, L Biganzoli, K L Blackwell, M J Cardoso, T Cufer, N El Saghir, L Fallowfield, D Fenech, P Francis, K Gelmon, S H Giordano, J Gligorov, A Goldhirsch, N Harbeck, N Houssami, C Hudis, B Kaufman, I Krop, S Kyriakides, U N Lin, M Mayer, S D Merjaver, E B Nordström, O Pagani, A Partridge, F Penault-Llorca, M J Piccart, H Rugo, G Sledge, C Thomssen, L Van't Veer, D Vorobiof, C Vrieling, N West, B Xu, E Winer, European School of Oncology, European Society of Medical Oncology |
| Journal | Breast (Edinburgh, Scotland)
(Breast)
Vol. 23
Issue 5
Pg. 489-502
(Oct 2014)
ISSN: 1532-3080 [Electronic] Netherlands |
| PMID | 25244983
(Publication Type: Consensus Development Conference, Journal Article, Practice Guideline)
|
| Chemical References |
- Biomarkers, Tumor
- Receptors, Estrogen
- ERBB2 protein, human
- Receptor, ErbB-2
|
| Topics |
- Biomarkers, Tumor
(metabolism)
- Breast Neoplasms
(metabolism, pathology, therapy)
- Combined Modality Therapy
- Female
- Humans
- Inflammatory Breast Neoplasms
(metabolism, pathology, therapy)
- Neoplasm Metastasis
- Neoplasm Staging
- Palliative Care
(methods)
- Quality of Life
- Receptor, ErbB-2
(metabolism)
- Receptors, Estrogen
(metabolism)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
